CoChat
Sign Up
Cited by 184Lipoproteins and Cardiovascular HealthCholesterol and Lipid MetabolismNatural Products and Biological Research

The DOI matches its Crossref record; 63 of the 65 references it cites were found in a registry or an index.

Assessment of the longer-term effects of a dietary portfolio of cholesterol-lowering foods in hypercholesterolemia

Open access
Jenkins, David JA, Kendall, Cyril WC, Faulkner, Dorothea A, Nguyen, Tri, Kemp, Thomas, Marchie, Augustine, Wong, Julia MW, de Souza, Russell, Emam, Azadeh, Vidgen, Edward, Trautwein, Elke A, Lapsley, Karen G, Holmes, Candice, Josse, Robert G, Leiter, Lawrence A, Connelly, Philip W, Singer, William·2006·The American Journal of Clinical Nutrition
DOI 10.1093/ajcn.83.3.582
Open this paper in CoChat — free account

Abstract

Background Cholesterol-lowering foods may be more effective when consumed as combinations rather than as single foods.Objectives Our aims were to determine the effectiveness of consuming a combination of cholesterol-lowering foods (dietary portfolio) under real-world conditions and to compare these results with published data from the same participants who had undergone 4-wk metabolic studies to compare the same dietary portfolio with the effects of a statin.Design For 12 mo, 66 hyperlipidemic participants were prescribed diets high in plant sterols (1.0 g/1000 kcal), soy protein (22.5 g/1000 kcal), viscous fibers (10 g/1000 kcal), and almonds (23 g/1000 kcal). Fifty-five participants completed the 1-y study. The 1-y data were also compared with published results on 29 of the participants who had also undergone separate 1-mo metabolic trials of a diet and a statin.Results At 3 mo and 1 y, mean (+/-SE) LDL-cholesterol reductions appeared stable at 14.0 +/- 1.6% (P < 0.001) and 12.8 +/- 2.0% (P < 0.001), respectively (n = 66). These reductions were less than those observed after the 1-mo metabolic diet and statin trials. Nevertheless, 31.8% of the participants (n = 21 of 66) had LDL-cholesterol reductions of >20% at 1 y (x +/- SE: -29.7 +/- 1.6%). The LDL-cholesterol reductions in this group were not significantly different from those seen after their respective metabolically controlled portfolio or statin treatments. A correlation was found between total dietary adherence and LDL-cholesterol change (r = -0.42, P < 0.001). Only 2 of the 26 participants with <55% compliance achieved LDL-cholesterol reductions >20% at 1 y.Conclusions More than 30% of motivated participants who ate the dietary portfolio of cholesterol-lowering foods under real-world conditions were able to lower LDL-cholesterol concentrations >20%, which was not significantly different from their response to a first-generation statin taken under metabolically controlled conditions.

Overview

Integrity signals

Registry

Crossref · 10.1093/ajcn.83.3.582

Cites

63 of 63 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Cited by

Sorted by citations

See all 184

Related

See all

Metadata

Authors
Jenkins, D. J., Kendall, C. W., Faulkner, D. A., Nguyen, T., Kemp, T., Marchie, A., Wong, J. M., de Souza, R., Emam, A., Vidgen, E., Trautwein, E. A., Lapsley, K. G., Holmes, C., Josse, R. G., Leiter, L. A., Connelly, P. W., & Singer, W.
Affiliations
St. Michael's Hospital (CA)
Corresponding author
Kendall, Cyril WC
ORCID
Venue
The American Journal of Clinical Nutrition
Publisher
Elsevier BV
Published
2006-03
Volume
83
Issue
3
Pages
582-591
ISSN
0002-9165 (ISSN-L)
DOI
10.1093/ajcn.83.3.582
OpenAlex
W2182342318
Cited by
184
References
65
Citations by year
2026: 2 · 2025: 4 · 2024: 6 · 2023: 5 · 2022: 3 · 2021: 9 · 2020: 5 · 2019: 8 · 2018: 5 · 2017: 7 · 2016: 8 · 2015: 11 · 2014: 8 · 2013: 10 · 2012: 6
FWCI
18.30
Type
journal article
Language
en
Open access
Licence
Locations
  • American Journal of Clinical Nutrition (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Natural Products and Biological Research
Keywords
hypercholesterolemia, LDL cholesterol lowering, phytosterols, soy protein, almond, dietary adherence, statin comparison, long-term dietary intervention, hyperlipidemia
MeSH terms
Adult, Aged, Aged, 80 and over, Anticholesteremic Agents, Cholesterol, Dietary, Combined Modality Therapy, Dietary Fiber, Female, Humans, Hypercholesterolemia, Cholesterol, LDL, Male, Middle Aged, Patient Compliance, Phytosterols, Treatment Outcome, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Prunus, Soybean Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review